ALK Positive Inc.

ALK Positive Inc.

@alkpositive.bsky.social

Patient-driven organization seeking a cure and working to improve patients' quality of life and life expectancy worldwide.

314 followers350 following294 posts

🌍 ALK Positive is headed to #ESMO2026! Dr. Ken Culver and Yvonne Diaz will be connecting with physicians, researchers, and global partners to advance ALK-positive cancer research and amplify patient voices worldwide.

🎥 The ALKtALK replay is now available! What’s new in ALK-positive cancer research, and what could it mean for you? Dr. Ken Culver shares clinical trial updates, emerging research, and a preview of our November Lung Cancer Awareness Month campaign! 💚 ▶️ Watch: youtu.be/r3ocrSEb-jc #ALKPositive

What does survivorship mean when living with ALK-positive cancer? In this ALKtALK clip, Dr. Eric Singhi shares why survivorship goes beyond treatment to include quality of life, adapting, and living well. 🎥 Watch the full replay: youtu.be/aIVlb1OiWxU #ALKPositive #ALKtALK

ALK Positive is at the 5th Summit on Thoracic Malignancies Our Executive & Medical Director, Dr. Ken Culver, is attending this invitation-only DAVA Oncology meeting alongside leading thoracic oncology experts advancing research and precision medicine. #ALKpositive

We're honored to announce Matthew Nielsen as the 2026 John Pender Scholarship recipient. Inspired by his mother's ALK+ diagnosis, Matthew is pursuing cancer research to help future families. Gina Hollenbeck looked to the stars. John Pender never gave up. Matthew carries their legacy forward. 💙

#ASCO2026 reinforced what’s possible when patients are part of the process. We connected with researchers, industry partners, and advocates, discussed emerging ALK+ cancer data, and helped shape future studies. We leave with new ideas, new partnerships, and renewed determination.

Live from ASCO: ALKtALK with Dr. Christine Lovly Get real-time updates from the ASCO Annual Meeting and what they mean for the ALK+ community—straight from a leading researcher and advocate. 📅 May 31, 2026 🕖 7 PM ET 📍 Zoom (broadcast live from ASCO) For patients, carepartners & advocates.

The 7-year CROWN data is in from #ASCO26. 💥 Key lorlatinib findings include long-term PFS, brain protection, and the importance of biomarker testing. Join us live Sunday, May 31 at 7pm ET as Dr. Christine Lovly discusses the results and other #ASCO26 updates. 💙

🔬 ALK Positive is heading to #ASCO26 in Chicago! Excited to learn from the latest ALK-positive lung cancer research, connect with the oncology community, and continue advocating for patients and families. If you’re attending, we hope to see you there! 👋 #ALKPositive